Back to top
more

Nu Skin Enterprises (NUS)

(Real Time Quote from BATS)

$7.11 USD

7.11
507,663

+0.56 (8.55%)

Updated Nov 11, 2024 12:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 16% (211 out of 250)

Industry: Cosmetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

NUS vs. IPAR: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

NUS vs. IPAR: Which Stock Is the Better Value Option?

Avon's (AVP) Open Up Strategy to Drive Long-Term Growth

by Zacks Equity Research

Avon's (AVP) Open Up strategy keeps the company on track to attain its financial targets for 2021.

    Nu Skin's Customer Base Bodes Well, Mainland China is a Worry

    by Zacks Equity Research

    Nu Skin (NUS) is battling headwinds in Mainland China that led to an unimpressive view for 2019. However, a rising customer base bodes well.

    Nu Skin Down 12% in 3 Months, Mainland China is a Concern

    by Zacks Equity Research

    Nu Skin (NUS) is battling headwinds in Mainland China, stemming from the government's campaign to scrutinize offerings of direct selling and health products industries.

    Nu Skin (NUS) Up 1.3% Since Last Earnings Report: Can It Continue?

    by Zacks Equity Research

    Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Nu Skin (NUS) Q2 Earnings In Line With Estimates, Sales Miss

    by Zacks Equity Research

    Headwinds in Mainland China were a drag on Nu Skin's (NUS) revenues and earnings in the second quarter of 2019.

    Nu Skin Enterprises (NUS) Meets Q2 Earnings Estimates

    by Zacks Equity Research

    Nu Skin (NUS) delivered earnings and revenue surprises of 0.00% and -1.53%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

    Is a Disappointment in Store for Nu Skin (NUS) Q2 Earnings?

    by Zacks Equity Research

    Nu Skin's (NUS) Q2 performance is likely to be hurt by the government campaign in Mainland China to inspect offerings of direct selling industries and health products.

    Analysts Estimate Nu Skin Enterprises (NUS) to Report a Decline in Earnings: What to Look Out for

    by Zacks Equity Research

    Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    NUS or IPAR: Which Is the Better Value Stock Right Now?

    by Zacks Equity Research

    NUS vs. IPAR: Which Stock Is the Better Value Option?

    Nu Skin Trims View on Anticipated Declines in Mainland China

    by Zacks Equity Research

    Nu Skin's (NUS) Q2 and 2019 results are likely to be hurt by weak performance in China, triggered by government's product review initiatives.

    Nu Skin Gains from Product Launches, Currency Rates Hurt

    by Zacks Equity Research

    Nu Skin's (NUS) customer base rises steadily, courtesy of effective marketing strategies and launches. However, adverse impacts of currency rates are concerns.

    Why Is Nu Skin (NUS) Down 25.1% Since Last Earnings Report?

    by Zacks Equity Research

    Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Nu Skin (NUS) Up 6% in a Month: Can It Maintain Momentum?

    by Zacks Equity Research

    Nu Skin (NUS) focuses on capturing greater market share through sales leaders. However, the company is battling currency headwinds.

    Nu Skin (NUS) Beats on Q1 Earnings & Revenues, Q2 View Soft

    by Zacks Equity Research

    The performance can be attributed to Nu Skin's (NUS) technology and business expansion initiatives as well as customer acquisition and retention program.

    Nu Skin Enterprises (NUS) Reports Next Week: Wall Street Expects Earnings Growth

    by Zacks Equity Research

    Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Here's What You Must Note Ahead of Nu Skin (NUS) Q1 Earnings

    by Zacks Equity Research

    Nu Skin's (NUS) is likely to benefit from effective marketing programs, gains from social media and a solid sales leaders' network. These factors are set to drive customer count in Q1.

    Nu Skin Boasts Customer Growth, Faces Weak Gross Margin

    by Zacks Equity Research

    Nu Skin (NUS) gains from an expanding customer base and prudent product launches. However, persistent decline in gross margin is a concern.

    Estee Lauder's Buyouts & Robust Online Business Bode Well

    by Zacks Equity Research

    Estee Lauder's (EL) solid focus on buyouts, travel retail network, effective launches and strong online sales are impressive.

    NUS vs. IPAR: Which Stock Is the Better Value Option?

    by Zacks Equity Research

    NUS vs. IPAR: Which Stock Is the Better Value Option?

    Nabaparna Bhattacharya headshot

    Can Value Investors Consider Nu Skin (NUS) Stock Now?

    by Nabaparna Bhattacharya

    Nu Skin (NUS) stock may be a good choice for value-oriented investors right now from multiple angles.

    Zacks.com featured highlights include: Materion, Boston Beer , Nu Skin, Darden and Comfort Systems

    by Zacks Equity Research

    Zacks.com featured highlights include: Materion, Boston Beer , Nu Skin, Darden and Comfort Systems

    Coty Picks Up Steam, Stock Rallies 59% Since Q2 Results

    by Zacks Equity Research

    Coty's (COTY) Luxury unit continues to deliver a strong show. Also, acquisitions and e-commerce efforts bode well amid hurdles like soft Consumer Beauty segment.

    Will Strong Demand Fuel United Natural's (UNFI) Q2 Earnings

    by Zacks Equity Research

    United Natural's (UNFI) Q2 results to gain from robust demand conditions and buyouts. However, rising fright costs and unfavorable consumer mix are concerns.

    Sanghamitra Saha headshot

    What Bargain Hunting? Bet on 5 Stocks With Rising P/E

    by Sanghamitra Saha

    Bet on these top-ranked stocks with rising P/E to realize outsized gains.